Immunohistochemical and clinicopathologic characteristics of invasive ductal carcinoma of breast with micropapillary carcinoma component
A micropapillary carcinoma (MC) component is generally considered to behave aggressively. Although several reports have described the prognostic significance of MC in breast carcinomas, immunohistochemical findings of MC, especially as compared to non-MC, are rarely described. We compared clinicopat...
Saved in:
Published in | Archives of pathology & laboratory medicine (1976) Vol. 129; no. 10; pp. 1277 - 1282 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
College of American Pathologists
01.10.2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A micropapillary carcinoma (MC) component is generally considered to behave aggressively. Although several reports have described the prognostic significance of MC in breast carcinomas, immunohistochemical findings of MC, especially as compared to non-MC, are rarely described.
We compared clinicopathologic and immunohistochemical findings between 38 cases of invasive breast carcinoma with an MC component (IMC) and 217 cases of invasive breast carcinoma without an MC component (NIMC).
We constructed a tissue microarray from 38 cases of IMC and performed immunohistochemical stainings for cytokeratin (CK) 7, CK20, estrogen receptor, progesterone receptor, p53, c-Erb-B2, CD34, CK5, epidermal growth factor receptor, and c-Kit in both MC and non-MC components.
Cases with IMC were associated with greater tumor size, more frequent lymphovascular invasion, nodal metastases, greater mean numbers of positive lymph nodes, and higher stage than those with NIMC, but were not associated with poorer survival rates. On immunohistochemistry, only p53 reactivity was statistically different between MC and non-MC components in IMC cases. Estrogen receptor positivity tended to be lower in MC than non-MC, but the difference was not significant. Most of the MCs and non-MCs in IMC cases were positive for CK7, but none of them were positive for CK20, CK5, epidermal growth factor receptor, or c-Kit.
Based on the frequent nodal metastases and association with higher stage found in IMC as compared with NIMC cases, as well as higher p53 positivity and lower frequency of estrogen receptor expression, MC could be considered an aggressive histologic type of breast carcinoma. In both MC and non-MC components in IMC cases, no basallike immunostaining pattern was detected. |
---|---|
AbstractList | CONTEXTA micropapillary carcinoma (MC) component is generally considered to behave aggressively. Although several reports have described the prognostic significance of MC in breast carcinomas, immunohistochemical findings of MC, especially as compared to non-MC, are rarely described. OBJECTIVEWe compared clinicopathologic and immunohistochemical findings between 38 cases of invasive breast carcinoma with an MC component (IMC) and 217 cases of invasive breast carcinoma without an MC component (NIMC). DESIGNWe constructed a tissue microarray from 38 cases of IMC and performed immunohistochemical stainings for cytokeratin (CK) 7, CK20, estrogen receptor, progesterone receptor, p53, c-Erb-B2, CD34, CK5, epidermal growth factor receptor, and c-Kit in both MC and non-MC components. RESULTSCases with IMC were associated with greater tumor size, more frequent lymphovascular invasion, nodal metastases, greater mean numbers of positive lymph nodes, and higher stage than those with NIMC, but were not associated with poorer survival rates. On immunohistochemistry, only p53 reactivity was statistically different between MC and non-MC components in IMC cases. Estrogen receptor positivity tended to be lower in MC than non-MC, but the difference was not significant. Most of the MCs and non-MCs in IMC cases were positive for CK7, but none of them were positive for CK20, CK5, epidermal growth factor receptor, or c-Kit. CONCLUSIONSBased on the frequent nodal metastases and association with higher stage found in IMC as compared with NIMC cases, as well as higher p53 positivity and lower frequency of estrogen receptor expression, MC could be considered an aggressive histologic type of breast carcinoma. In both MC and non-MC components in IMC cases, no basallike immunostaining pattern was detected. A micropapillary carcinoma (MC) component is generally considered to behave aggressively. Although several reports have described the prognostic significance of MC in breast carcinomas, immunohistochemical findings of MC, especially as compared to non-MC, are rarely described. We compared clinicopathologic and immunohistochemical findings between 38 cases of invasive breast carcinoma with an MC component (IMC) and 217 cases of invasive breast carcinoma without an MC component (NIMC). We constructed a tissue microarray from 38 cases of IMC and performed immunohistochemical stainings for cytokeratin (CK) 7, CK20, estrogen receptor, progesterone receptor, p53, c-Erb-B2, CD34, CK5, epidermal growth factor receptor, and c-Kit in both MC and non-MC components. Cases with IMC were associated with greater tumor size, more frequent lymphovascular invasion, nodal metastases, greater mean numbers of positive lymph nodes, and higher stage than those with NIMC, but were not associated with poorer survival rates. On immunohistochemistry, only p53 reactivity was statistically different between MC and non-MC components in IMC cases. Estrogen receptor positivity tended to be lower in MC than non-MC, but the difference was not significant. Most of the MCs and non-MCs in IMC cases were positive for CK7, but none of them were positive for CK20, CK5, epidermal growth factor receptor, or c-Kit. Based on the frequent nodal metastases and association with higher stage found in IMC as compared with NIMC cases, as well as higher p53 positivity and lower frequency of estrogen receptor expression, MC could be considered an aggressive histologic type of breast carcinoma. In both MC and non-MC components in IMC cases, no basallike immunostaining pattern was detected. A micropapillary carcinoma (MC) component is generally considered to behave aggressively. Although several reports have described the prognostic significance of MC in breast carcinomas, immunohistochemical findings of MC, especially as compared to non-MC, are rarely described. We compared clinicopathologic and immunohistochemical findings between 38 cases of invasive breast carcinoma with an MC component (IMC) and 217 cases of invasive breast carcinoma without an MC component (NIMC). We constructed a tissue microarray from 38 cases of IMC and performed immunohistochemical stainings for cytokeratin (CK) 7, CK20, estrogen receptor, progesterone receptor, p53, c-Erb-B2, CD34, CK5, epidermal growth factor receptor, and c-Kit in both MC and non-MC components. Cases with IMC were associated with greater tumor size, more frequent lymphovascular invasion, nodal metastases, greater mean numbers of positive lymph nodes, and higher stage than those with NIMC, but were not associated with poorer survival rates. On immunohistochemistry, only p53 reactivity was statistically different between MC and non-MC components in IMC cases. Estrogen receptor positivity tended to be lower in MC than non-MC, but the difference was not significant. Most of the MCs and non-MCs in IMC cases were positive for CK7, but none of them were positive for CK20, CK5, epidermal growth factor receptor, or c-Kit. Based on the frequent nodal metastases and association with higher stage found in IMC as compared with NIMC cases, as well as higher p53 positivity and lower frequency of estrogen receptor expression, MC could be considered an aggressive histologic type of breast carcinoma. In both MC and non-MC components in IMC cases, no basallike immunostaining pattern was detected. Abstract Context.—A micropapillary carcinoma (MC) component is generally considered to behave aggressively. Although several reports have described the prognostic significance of MC in breast carcinomas, immunohistochemical findings of MC, especially as compared to non-MC, are rarely described. Objective.—We compared clinicopathologic and immunohistochemical findings between 38 cases of invasive breast carcinoma with an MC component (IMC) and 217 cases of invasive breast carcinoma without an MC component (NIMC). Design.—We constructed a tissue microarray from 38 cases of IMC and performed immunohistochemical stainings for cytokeratin (CK) 7, CK20, estrogen receptor, progesterone receptor, p53, c-Erb-B2, CD34, CK5, epidermal growth factor receptor, and c-Kit in both MC and non-MC components. Results.—Cases with IMC were associated with greater tumor size, more frequent lymphovascular invasion, nodal metastases, greater mean numbers of positive lymph nodes, and higher stage than those with NIMC, but were not associated with poorer survival rates. On immunohistochemistry, only p53 reactivity was statistically different between MC and non-MC components in IMC cases. Estrogen receptor positivity tended to be lower in MC than non-MC, but the difference was not significant. Most of the MCs and non-MCs in IMC cases were positive for CK7, but none of them were positive for CK20, CK5, epidermal growth factor receptor, or c-Kit. Conclusions.—Based on the frequent nodal metastases and association with higher stage found in IMC as compared with NIMC cases, as well as higher p53 positivity and lower frequency of estrogen receptor expression, MC could be considered an aggressive histologic type of breast carcinoma. In both MC and non-MC components in IMC cases, no basallike immunostaining pattern was detected. |
Author | Kim, Mi-Jung Gong, Gyungyub Ahn, Se-Hyun Joo, Hee Jae Ro, Jae Y |
Author_xml | – sequence: 1 givenname: Mi-Jung surname: Kim fullname: Kim, Mi-Jung organization: Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea – sequence: 2 givenname: Gyungyub surname: Gong fullname: Gong, Gyungyub – sequence: 3 givenname: Hee Jae surname: Joo fullname: Joo, Hee Jae – sequence: 4 givenname: Se-Hyun surname: Ahn fullname: Ahn, Se-Hyun – sequence: 5 givenname: Jae Y surname: Ro fullname: Ro, Jae Y |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16196516$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkctq3DAUhkVJaWbSvkEIpovu3Opi3ZZhSNqBQDbtWsjHmlrBlhxJTukb9LGrYQYauhBC6Ds_5-fboosQg0PomuDPXHH1hWLMW0J1PVK2-9vd7nH_Bm0I71hLieAXaIMxZq3Wil-ibc5P9akpJe_QJRFEC07EBv3Zz_Ma4uhziTC62YOdGhuGBiYfPMTFljFO8aeHBkabLBSXKushN_HQ-PBis39xzbBCqYNgE_gQZ3v87JOzuTS_fBmbmptq1uKnyabfrziI81J7hfIevT3YKbsP5_sK_bi_-7771j48ft3vbh9aYIyWVklnbW2utMU91VwPuKOSa2Udc0xxIcTABuZACyJx3wsMPTipOUjQICS7Qp9OuUuKz6vLxcw-g6t7BRfXbIQSHe1wV8GP_4FPcU2h7mYoIbpTkpMKdSeo1ss5uYNZkp9rRUOwOWoyR02majJHTeakqY7dnLPXfnbDv6GzF_YXOB2Tfg |
CODEN | APLMAS |
CitedBy_id | crossref_primary_10_1111_j_1365_2559_2007_02884_x crossref_primary_10_1111_j_1524_4741_2009_00693_x crossref_primary_10_1097_PAI_0000000000000167 crossref_primary_10_1093_jjco_hyq056 crossref_primary_10_4048_jbc_2010_13_2_174 crossref_primary_10_1111_tbj_13432 crossref_primary_10_1097_PAP_0b013e318234aaed crossref_primary_10_2214_AJR_08_1537 crossref_primary_10_5858_arpa_2020_0288_OA crossref_primary_10_1016_S1077_9108_08_70268_8 crossref_primary_10_1016_j_ctrc_2014_12_001 crossref_primary_10_2214_AJR_12_8512 crossref_primary_10_1016_j_ijscr_2017_07_048 crossref_primary_10_4048_jbc_2012_15_1_57 crossref_primary_10_3892_ol_2020_11848 crossref_primary_10_1177_1066896911399279 crossref_primary_10_3389_fsurg_2022_1011773 crossref_primary_10_1080_01913120802179473 crossref_primary_10_1007_s10147_010_0093_2 crossref_primary_10_1177_1066896912436552 crossref_primary_10_5858_133_6_893 crossref_primary_10_1016_j_ejrad_2014_05_003 crossref_primary_10_1186_s40880_019_0406_4 crossref_primary_10_5858_arpa_2021_0091_RA crossref_primary_10_1111_j_1524_4741_2012_01232_x crossref_primary_10_1354_vp_44_6_842 crossref_primary_10_1007_s12609_021_00436_w crossref_primary_10_1111_j_1440_1827_2011_02735_x crossref_primary_10_2217_whe_15_99 crossref_primary_10_1093_annonc_mdp245 crossref_primary_10_1016_j_clbc_2012_10_001 crossref_primary_10_1354_vp_45_4_600 crossref_primary_10_1038_bjc_2014_301 crossref_primary_10_1016_j_tvjl_2012_08_022 crossref_primary_10_1002_cam4_5595 crossref_primary_10_1016_j_clbc_2015_01_008 crossref_primary_10_1016_j_humpath_2007_09_009 crossref_primary_10_1038_s41598_018_36362_8 crossref_primary_10_1177_1066896908329586 crossref_primary_10_12688_f1000research_122339_1 crossref_primary_10_1111_j_1440_1827_2007_02159_x crossref_primary_10_1186_s12885_019_6295_8 crossref_primary_10_1002_path_2368 crossref_primary_10_1172_JCI24311 crossref_primary_10_4132_KoreanJPathol_2011_45_2_125 crossref_primary_10_2147_BCTT_S346301 crossref_primary_10_1136_bmjopen_2023_072632 crossref_primary_10_1016_j_xgen_2021_100067 crossref_primary_10_3816_CBC_2009_n_043 |
Cites_doi | 10.1093/ajcp/73.3.313 10.1111/j.1365-2559.2004.01757.x 10.1016/S0046-8177(99)90168-5 10.1097/00000478-200403000-00004 10.1097/00004347-200301000-00008 10.1016/S0344-0338(11)80745-4 10.1016/S0344-0338(96)80126-9 10.1158/1078-0432.CCR-04-0220 10.1002/cncr.20125 10.1053/hupa.2002.124034 10.1038/modpathol.3880399 10.1073/pnas.191367098 10.1097/00000478-199412000-00005 10.1016/S0344-0338(00)80019-9 10.1097/00000478-200203000-00010 10.1016/S1092-9134(02)91216-5 10.1053/hupa.2001.24988 10.1046/j.1524-4741.2003.09423.x |
ContentType | Journal Article |
Copyright | Copyright College of American Pathologists Oct 2005 |
Copyright_xml | – notice: Copyright College of American Pathologists Oct 2005 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 4T- 4U- 7RV 7X7 7XB 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. KB0 LK8 M0S M1P M2P M7P NAPCQ PQEST PQQKQ PQUKI PRINS Q9U 7X8 |
DOI | 10.5858/2005-129-1277-IACCOI |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Docstoc University Readers Proquest Nursing & Allied Health Source ProQuest_Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection ProQuest Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest Science Journals Biological Science Database Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef University Readers ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Docstoc ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic University Readers MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1543-2165 |
EndPage | 1282 |
ExternalDocumentID | 908578211 10_5858_2005_129_1277_IACCOI 16196516 |
Genre | Journal Article Comparative Study |
GroupedDBID | --- -~X .55 .GJ 04C 1CY 23N 2WC 36B 3O- 3V. 53G 5GY 5RE 6PF 7RV 7X7 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8R4 8R5 AAQOH AAQQT AAWTL ABCQX ABDBF ABOCM ABUWG ACGFO ACGOD ACPRK ADBBV ADOJX AENEX AFFNX AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AZQEC B0M BAWUL BBNVY BENPR BHPHI BKEYQ BKOMP BMSDO BPHCQ BVXVI C1A CCPQU CGR CUY CVF DIK DWQXO E3Z EAP EAS EBC EBD EBS ECF ECM ECT ECV EHN EIF EIHBH EJD EMB EMK EMOBN ENC EPL EPT ESX EX3 F5P FAC FAL FJD FJW FRP FYUFA GNUQQ GX1 HCIFZ HMCUK IAO IEA IHR IHW INH INR IOF ITC J5H L7B LK8 M1P M2P M2Q M7P NAPCQ NPM OK1 P2P PCD PQQKQ PROAC PSQYO PV9 Q2X Q~Q RWL RXW RZL SV3 TAE TAF TR2 TUS TWZ UDS UKHRP W2D WH7 WOW WQ9 X6Y X7M Y3D YQJ ZGI ZXP ~8M AAYXX CITATION 4T- 4U- 7XB 8FK K9. PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c332t-87eaa00589a0b2959d0427598ae3e385666d3d3ec96170bb60cbce795c7c9c673 |
IEDL.DBID | BENPR |
ISSN | 0003-9985 |
IngestDate | Sat Aug 17 02:32:15 EDT 2024 Thu Oct 10 17:21:25 EDT 2024 Fri Aug 23 02:09:31 EDT 2024 Sat Sep 28 07:48:43 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c332t-87eaa00589a0b2959d0427598ae3e385666d3d3ec96170bb60cbce795c7c9c673 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 16196516 |
PQID | 211948751 |
PQPubID | 42082 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_68642404 proquest_journals_211948751 crossref_primary_10_5858_2005_129_1277_IACCOI pubmed_primary_16196516 |
PublicationCentury | 2000 |
PublicationDate | 2005-Oct 2005-10-01 20051001 |
PublicationDateYYYYMMDD | 2005-10-01 |
PublicationDate_xml | – month: 10 year: 2005 text: 2005-Oct |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Northfield |
PublicationTitle | Archives of pathology & laboratory medicine (1976) |
PublicationTitleAlternate | Arch Pathol Lab Med |
PublicationYear | 2005 |
Publisher | College of American Pathologists |
Publisher_xml | – name: College of American Pathologists |
References | Zekioglu (2021020922014228800_i1543-2165-129-10-1277-b6) 2004; 44 Amin (2021020922014228800_i1543-2165-129-10-1277-b10) 2002; 26 Fisher (2021020922014228800_i1543-2165-129-10-1277-b1) 1980; 73 Middleton (2021020922014228800_i1543-2165-129-10-1277-b16) 1999; 12 Ramalingam (2021020922014228800_i1543-2165-129-10-1277-b20) 2003; 7 Luna-More (2021020922014228800_i1543-2165-129-10-1277-b3) 1994; 190 Nielsen (2021020922014228800_i1543-2165-129-10-1277-b9) 2004; 10 Siriaunkgul (2021020922014228800_i1543-2165-129-10-1277-b2) 1993; 6 Luna-More (2021020922014228800_i1543-2165-129-10-1277-b15) 1996; 192 Amendoeira (2021020922014228800_i1543-2165-129-10-1277-b19) 2003; 9 Thor (2021020922014228800_i1543-2165-129-10-1277-b18) 2002; 33 Nagao (2021020922014228800_i1543-2165-129-10-1277-b13) 2004; 28 Gilks (2021020922014228800_i1543-2165-129-10-1277-b14) 2003; 22 Nassar (2021020922014228800_i1543-2165-129-10-1277-b5) 2001; 14 Hoshi (2021020922014228800_i1543-2165-129-10-1277-b12) 2004; 102 Amin (2021020922014228800_i1543-2165-129-10-1277-b11) 1994; 18 Walsh (2021020922014228800_i1543-2165-129-10-1277-b7) 2001; 32 Sorlie (2021020922014228800_i1543-2165-129-10-1277-b8) 2001; 98 Paterakos (2021020922014228800_i1543-2165-129-10-1277-b4) 1999; 30 Luna-More (2021020922014228800_i1543-2165-129-10-1277-b17) 2000; 196 |
References_xml | – volume: 73 start-page: 313 year: 1980 ident: 2021020922014228800_i1543-2165-129-10-1277-b1 article-title: Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4), VI: invasive papillary cancer. publication-title: Am J Clin Pathol doi: 10.1093/ajcp/73.3.313 contributor: fullname: Fisher – volume: 44 start-page: 18 year: 2004 ident: 2021020922014228800_i1543-2165-129-10-1277-b6 article-title: Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. publication-title: Histopathology doi: 10.1111/j.1365-2559.2004.01757.x contributor: fullname: Zekioglu – volume: 30 start-page: 1459 year: 1999 ident: 2021020922014228800_i1543-2165-129-10-1277-b4 article-title: Invasive micropapillary carcinoma of the breast: a prognostic study. publication-title: Hum Pathol doi: 10.1016/S0046-8177(99)90168-5 contributor: fullname: Paterakos – volume: 28 start-page: 319 year: 2004 ident: 2021020922014228800_i1543-2165-129-10-1277-b13 article-title: Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance. publication-title: Am J Surg Pathol doi: 10.1097/00000478-200403000-00004 contributor: fullname: Nagao – volume: 22 start-page: 29 year: 2003 ident: 2021020922014228800_i1543-2165-129-10-1277-b14 article-title: Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases. publication-title: Int J Gynecol Pathol doi: 10.1097/00004347-200301000-00008 contributor: fullname: Gilks – volume: 190 start-page: 668 year: 1994 ident: 2021020922014228800_i1543-2165-129-10-1277-b3 article-title: Invasive micropapillary carcinoma of the breast: a new special type of invasive mammary carcinoma. publication-title: Pathol Res Pract doi: 10.1016/S0344-0338(11)80745-4 contributor: fullname: Luna-More – volume: 192 start-page: 27 year: 1996 ident: 2021020922014228800_i1543-2165-129-10-1277-b15 article-title: Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas. publication-title: Pathol Res Pract doi: 10.1016/S0344-0338(96)80126-9 contributor: fullname: Luna-More – volume: 10 start-page: 5367 year: 2004 ident: 2021020922014228800_i1543-2165-129-10-1277-b9 article-title: Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-04-0220 contributor: fullname: Nielsen – volume: 102 start-page: 81 year: 2004 ident: 2021020922014228800_i1543-2165-129-10-1277-b12 article-title: Micropapillary clusters in early-stage lung adenocarcinomas: a distinct cytologic sign of significantly poor prognosis. publication-title: Cancer doi: 10.1002/cncr.20125 contributor: fullname: Hoshi – volume: 33 start-page: 628 year: 2002 ident: 2021020922014228800_i1543-2165-129-10-1277-b18 article-title: Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization. publication-title: Hum Pathol doi: 10.1053/hupa.2002.124034 contributor: fullname: Thor – volume: 12 start-page: 499 year: 1999 ident: 2021020922014228800_i1543-2165-129-10-1277-b16 article-title: Infiltrating micropapillary carcinoma of the breast. publication-title: Mod Pathol contributor: fullname: Middleton – volume: 14 start-page: 836 year: 2001 ident: 2021020922014228800_i1543-2165-129-10-1277-b5 article-title: Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. publication-title: Mod Pathol doi: 10.1038/modpathol.3880399 contributor: fullname: Nassar – volume: 6 start-page: 660 year: 1993 ident: 2021020922014228800_i1543-2165-129-10-1277-b2 article-title: Invasive micropapillary carcinoma of the breast. publication-title: Mod Pathol contributor: fullname: Siriaunkgul – volume: 98 start-page: 10869 year: 2001 ident: 2021020922014228800_i1543-2165-129-10-1277-b8 article-title: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.191367098 contributor: fullname: Sorlie – volume: 18 start-page: 1224 year: 1994 ident: 2021020922014228800_i1543-2165-129-10-1277-b11 article-title: Micropapillary variant of transitional cell carcinoma of the urinary bladder: histologic pattern resembling ovarian papillary serous carcinoma. publication-title: Am J Surg Pathol doi: 10.1097/00000478-199412000-00005 contributor: fullname: Amin – volume: 196 start-page: 35 year: 2000 ident: 2021020922014228800_i1543-2165-129-10-1277-b17 article-title: Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast: review of 68 cases with follow-up of 54. publication-title: Pathol Res Pract doi: 10.1016/S0344-0338(00)80019-9 contributor: fullname: Luna-More – volume: 26 start-page: 358 year: 2002 ident: 2021020922014228800_i1543-2165-129-10-1277-b10 article-title: Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. publication-title: Am J Surg Pathol doi: 10.1097/00000478-200203000-00010 contributor: fullname: Amin – volume: 7 start-page: 112 year: 2003 ident: 2021020922014228800_i1543-2165-129-10-1277-b20 article-title: Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features. publication-title: Ann Diagn Pathol doi: 10.1016/S1092-9134(02)91216-5 contributor: fullname: Ramalingam – volume: 32 start-page: 583 year: 2001 ident: 2021020922014228800_i1543-2165-129-10-1277-b7 article-title: Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. publication-title: Hum Pathol doi: 10.1053/hupa.2001.24988 contributor: fullname: Walsh – volume: 9 start-page: 337 year: 2003 ident: 2021020922014228800_i1543-2165-129-10-1277-b19 article-title: Invasive micropapillary carcinoma of the breast: are the pure forms more aggressive than the mixed forms? publication-title: Breast J doi: 10.1046/j.1524-4741.2003.09423.x contributor: fullname: Amendoeira |
SSID | ssj0009221 |
Score | 2.0691218 |
Snippet | A micropapillary carcinoma (MC) component is generally considered to behave aggressively. Although several reports have described the prognostic significance... Abstract Context.—A micropapillary carcinoma (MC) component is generally considered to behave aggressively. Although several reports have described the... CONTEXTA micropapillary carcinoma (MC) component is generally considered to behave aggressively. Although several reports have described the prognostic... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 1277 |
SubjectTerms | Adult Aged Aged, 80 and over Biomarkers, Tumor - analysis Breast Neoplasms - chemistry Breast Neoplasms - mortality Breast Neoplasms - pathology Carcinoma, Ductal, Breast - chemistry Carcinoma, Ductal, Breast - mortality Carcinoma, Ductal, Breast - secondary Carcinoma, Papillary - chemistry Carcinoma, Papillary - mortality Carcinoma, Papillary - secondary Female Humans Immunoenzyme Techniques Lymph Nodes - pathology Lymphatic Metastasis Middle Aged Survival Rate Tissue Array Analysis - methods |
Title | Immunohistochemical and clinicopathologic characteristics of invasive ductal carcinoma of breast with micropapillary carcinoma component |
URI | https://www.ncbi.nlm.nih.gov/pubmed/16196516 https://www.proquest.com/docview/211948751 https://search.proquest.com/docview/68642404 |
Volume | 129 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV07T8MwED4BlRAL4k15emC1iJ04jwlBoKJILQhR0S2yHUcwkBSaIvEP-Nn4GrfAAEsWR7bkO58_-87fB3BSCFlwzRPKFYtpYDxDlWaKRrHSPAildRO8h-z1w-tBcDMUQ1ebM3ZllbOYOA3UeaXxjvwUmcgQXLOz0StF0ShMrjoFjUVocRZglrZ1cdW_u_9m3eV8LplnzxWieTtnEXJ82lBwctQCiCLaPU_T2-7vvekPwDndeDprsOoQIzlvTLwOC6bcgOWey4lvwmcXn3hUU-Jg7Z7_E1nmpKH8rFBzuIlwJP3NzkyqgnTLd4kV7ORyoi0OJylqC5XVi8TGC6xYr8njc_1Eeli5N5IjVCl6-_jxH0aUqrR71xYMOlcP6TV1-gpU-z6vbSA0Uk51BaWneCKSHIU3RBJL4xs_tkAvzP3cNzpB1nalQk8rbaJE6EgnOoz8bVgq7QC7QHRgMA8scuGZgOVMWWQQG1Mk2rfwvTBtoLOZzUYNjUZmjx9oCRTCFJm1RIaWyBpLtGF_Nv2ZW1TjbO4CbTiet9rVgCkOWZpqMs7C2J6nAi9ow05js-_RQuROZOHevz3vw8qMm9VjB7BUv03MoUUdtTqCxWgY2W-csiPnZ1_rV9jL |
link.rule.ids | 315,786,790,12083,12250,21416,27955,27956,31752,31753,33299,33300,33777,33778,43343,43612,43838,74100,74369,74657 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT9wwEB0VKkEvCAqly6cPXC0SO07iE4IA2rQsvYDgZtmOIziQLLvZSv0H_Gw8SXaBQzk7iiWPPfPsmXkP4KgUumSWScpMmNLIBY4aGxqapMayKNZ-m-A75Og6Ht5Gv-7FfV-bM-3LKuc-sXXURW3xjfwYmcgQXIcn42eKolGYXO0VNJbga8R9qMZG8eytwkMythDM87cK0XXOeXycHncEnAyVAJKE5qdZ9if_GJn-AzfbsHO5Dms9XiSnnYE34IurvsPKqM-Ib8JLjg0edUsbbPvmf6KrgnSEnzUqDnf-jWQfuZlJXZK8-quxfp2cz6xH4SRDZaGqftI4eIb16g25e2weyAjr9sZ6jBpFk3_vvkN_Ulc-cm3B7eXFTTakvboCtZyzxrtBp3WrKqgDw6SQBcpuCJlqxx1PPcyLC15wZyVythsTB9ZYl0hhEyttnPAfsFz5CX4CsZHDLLAoROCisAiNxwWpc6W03IP30g2AzldWjTsSDeUvH2gJlMEUyltCoSVUZ4kB7M6XX_VHaqoWG2AAh4tRfxYwwaErV8-mKk79bSoKogFsdzZ7my1G5sQw3vn0z4ewOrwZXamr_Pr3Lnybs7QG4R4sN5OZ2_f4ozEH7S57BSEb2Gk |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT9wwEB21IKFeKujnllJ86NXaxImd5IQgsCJtd4sQqNws23HUHpps2Wwl_gE_uzMb71IO7dlRLHnG4zee8XsAHxtpGuFEwYWNc576yHPrYsuz3DqRKoNuQveQ05k6v04_3cibQCm0CG2V65i4CtR15-iOfExMZASu43ETuiIuTidH81-cBKSo0BrUNJ7CdpYqiXnY9snZ7OLygYFXiI18HuYYcnhHh2g5Hw90nIJ0AbKMV8dl-bV6fE79A3yuDqHJLjwP6JEdD-begye-fQE701Affwn3FT336FYkwi5QATDT1myg_-xIf3iIdqx8zNTMuoZV7W9D3ezsdOkQk7OSdIba7qehwRPqXu_Ztx_9dzalLr65mZNi0e3dX99RdOlaPMdewfXk7Ko850FrgbskET0GRW_MSmPQRFYUsqhJhEMWufGJT3IEfapO6sS7ghjcrVWRs85nhXSZK5zKktew1eIEb4G51FNNWNYy8mlcxxZRQu59U7gEoXzjR8DXK6vnA6WGxlSELEGimFKjJTRZQg-WGMH-evl12GALvXGHERxuRnFnULnDtL5bLrTKMbdKo3QEbwabPcymiEcxVu_---dD2EEX01-q2ed9eLambI3i97DV3y79AYKR3n4IbvYHQnzeQQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunohistochemical+and+Clinicopathologic+Characteristics+of+Invasive+Ductal+Carcinoma+of+Breast+With+Micropapillary+Carcinoma+Component&rft.jtitle=Archives+of+pathology+%26+laboratory+medicine+%281976%29&rft.au=Mi-Jung%2C+Kim&rft.au=Gong%2C+Gyungyub&rft.au=Joo%2C+Hee+Jae&rft.au=Se-Hyun+Ahn&rft.date=2005-10-01&rft.pub=College+of+American+Pathologists&rft.issn=0003-9985&rft.eissn=1543-2165&rft.volume=129&rft.issue=10&rft.spage=1277&rft_id=info:doi/10.5858%2F2005-129-1277-IACCOI&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=908578211 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-9985&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-9985&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-9985&client=summon |